Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 686 of 6351
-
New injection could help shed pounds in obesity trial
Disease control OngoingThis is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study in adult obese/overweight subjects in China to evaluate the efficacy and safety of GZR18 Injection in the subjects.
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Acupuncture with electric pulses may guard the brain's memory circuits
Disease control Recruiting nowSubjective cognitive decline (SCD) is the early diagnosis and treatment window period of Alzheimer's disease (AD), and the identification of SCD individuals who will progress to AD (pSCD) is a research hotspot. Based on olfactory fMRI,previous studies have found that SCD individu…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Pregnancy hepatitis b drug showdown: which is safer for mom and baby?
Disease control By invitation onlyThe goal of this clinical trial is to learn the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy antiviral therapy for chronic hepatitis B pregnant women. The main questions it aims to answer are: The rate of…
Phase 4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nasal light zaps infection risk before surgery
Prevention CompletedThis is a Phase 3 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in patients undergoing major elective, urgent, or emergent surgeries in a hospital se…
Phase 3 • Sponsor: Ondine Biomedical Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Can less chemo be enough? new trial tailors treatment for early breast cancer
Disease control Recruiting nowTriple-negative breast cancer (TNBC) is a group of tumors that occurs mainly in young, premenopausal women and accounts for 10-20% of breast cancers. Over the past decade, the incidence of women diagnosed with early-stage TNBC has significantly increased due to the widespread use…
Phase 2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Virus injection targets pancreatic tumors in new trial
Disease control Recruiting nowThis is a single center, Phase I dose finding study of a single direct tumor injection of an RGD modified conditionally replicative adenovirus (RGDCRAdcox2F) in persons with adenocarcinoma of the pancreas. The study is designed to determine the MTD of RGDCRAdCOX2F that correspond…
Phase 1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a simple zinc pill save thousands of newborns from deadly infections?
Disease control Recruiting nowBacterial infections among young infants, including sepsis, meningitis, and pneumonia, continue to cause a substantial number of deaths globally. Zinc supplementation in combination with standard antibiotic therapy may represent a new intervention to reduce mortality and improve …
Phase 3 • Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Tiny radioactive spheres aim to destroy kidney tumors without surgery
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects and effectiveness of radioembolization with yttrium-90 (Y-90) in patients with early stage renal cell carcinoma. Y-90 is a radioactive chemical that is incorporated into millions of very tiny glass spheres. These spheres are in…
Phase 1/2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Stem cell treatment shows promise for stubborn leg wounds
Disease control OngoingThe aim of this clinical trial is to investigate the efficacy and safety of allo-APZ2-CVU, administered topically on therapy-resistant non-healing CVUs compared to placebo.
Phase 3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Promising drug cocktail targets Hard-to-Treat ovarian cancer
Disease control OngoingThis single arm phase II study proposes to evaluate the efficacy and safety of nab-sirolimus + endocrine therapy (Fulvestrant) in patients with recurrent low grade serous ovarian cancer (LGSOC).
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a steroid injection into the ear beat oral pills for sudden hearing loss?
Disease control Recruiting nowThe goal of this clinical trial is to learn which one works to treat better in patients with sudden sensorineural hearing loss, oral or intratympanic corticosteroid treatment. The main question it aims to answer is: Which corticosteroid treatment is more effective in patients w…
Phase 4 • Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare blood cancers: targeted drug trial opens
Disease control Recruiting nowIndolent T/NK-cell lymphomas are a heterogeneous group of lymphoproliferative diseases originating from T/NK cells, characterized by slow growth and proliferation, but currently remain incurable. For indolent T/NK-cell lymphomas that are unresponsive to first-line treatment, ther…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for chemo-resistant breast cancer: targeted radiation before surgery
Disease control Recruiting nowThe goal of this clinical trial is to assess whether the addition of preoperative stereotactic body radiation therapy (SBRT) can improve pathological complete response (pCR) rates and safety in breast cancer patients who do not respond to initial neoadjuvant chemotherapy. The mai…
Phase 1/2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Engineered immune cells take on Hard-to-Treat lung cancer
Disease control Recruiting nowThis single-arm, open-label, multicenter, Phase I study will evaluate the safety, tolerability, anti-tumor activity, pharmacokinetics (PK)/pharmacodynamics (PD), biomarker, and immunogenicity of C-CAR031 in adult participants with GPC3+ advanced/metastatic squamous cell lung canc…
Phase 1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New balloon treatment could rival standard stent for heart attacks
Disease control Recruiting nowThe objective of the study is to compare drug-coated balloon (DCB) with the gold standard drug-eluting stent (DES) in percutaneous coronary intervention (PCI) for patients presenting with ST-elevation myocardial infarction (STEMI). Randomization will be performed after successfu…
Sponsor: Institute of Cardiovascular Diseases, Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
MRI 'Fingerprint' may reveal which head and neck tumors vanish with Pre-Surgery therapy
Diagnosis Recruiting nowHead and neck squamous cell carcinoma is the sixth most common malignant tumor in the world. Neoadjuvant therapy, including neoadjuvant chemotherapy and immunotherapy, is recommended for patients with locally advanced head and neck cancer. The response to neoadjuvant therapy vari…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
App could make methadone treatment easier and cheaper
Disease control Recruiting nowMethadone is an effective treatment for severe opioid use disorder (OUD), but access is limited due to the requirement of daily observed dosing by most opioid treatment programs (OTPs). Sonara Health designed a HIPAA-compliant web-application called Sonara that features integrate…
Phase 2 • Sponsor: Sonara Health • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Engineered immune cells take on lupus in early trial
Disease control Recruiting nowA Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Moderate to Severe Active Systemic Lupus Erythematosus
Early phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New trial tests quick valve fix after heart attack to save lives
Disease control Recruiting nowTo explore the impact of early transcatheter edge-to-edge repair of acute functional mitral regurgitation after myocardial infarction on the combined incidence of death and heart-failure associated hospitalisations at one-year follow-up, and quality of life and LV remodelling at …
Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Immunotherapy plus chemo shows promise for rare sinus cancer
Disease control Recruiting nowThis study will test the Safety and activity of pembrolizumab plus chemotherapy as neoadjuvant treatment in locally advanced sinonasal undifferentiated carcinoma (SNUC). Activity of neoadjuvant chemotherapy in locally advanced SNUC has been already demonstrated; the primary hypo…
Phase 2 • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC